SARTORIUS AG-VORZUG (SRT3.DE) Stock Fundamental Analysis
FRA:SRT3 - Deutsche Boerse Ag - DE0007165631 - Currency: EUR
Taking everything into account, SRT3 scores 3 out of 10 in our fundamental rating. SRT3 was compared to 15 industry peers in the Life Sciences Tools & Services industry. SRT3 may be in some trouble as it scores bad on both profitability and health. SRT3 is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
SRT3 had positive earnings in the past year.
SRT3 had a positive operating cash flow in the past year.
Each year in the past 5 years SRT3 has been profitable.
SRT3 had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of 0.83%, SRT3 is doing worse than 73.33% of the companies in the same industry.
Looking at the Return On Equity, with a value of 3.03%, SRT3 is doing worse than 66.67% of the companies in the same industry.
With a Return On Invested Capital value of 3.37%, SRT3 is not doing good in the industry: 80.00% of the companies in the same industry are doing better.
SRT3 had an Average Return On Invested Capital over the past 3 years of 8.34%. This is in line with the industry average of 6.90%.
The last Return On Invested Capital (3.37%) for SRT3 is well below the 3 year average (8.34%), which needs to be investigated, but indicates that SRT3 had better years and this may not be a problem.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.83% | ||
| ROE | 3.03% | ||
| ROIC | 3.37% |
ROA(3y)4.22%
ROA(5y)4.59%
ROE(3y)15.69%
ROE(5y)18.55%
ROIC(3y)8.34%
ROIC(5y)10.45%
1.3 Margins
The Profit Margin of SRT3 (2.48%) is worse than 73.33% of its industry peers.
In the last couple of years the Profit Margin of SRT3 has declined.
Looking at the Operating Margin, with a value of 11.60%, SRT3 is doing worse than 66.67% of the companies in the same industry.
SRT3's Operating Margin has declined in the last couple of years.
SRT3 has a Gross Margin of 45.09%. This is in the better half of the industry: SRT3 outperforms 73.33% of its industry peers.
SRT3's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 11.6% | ||
| PM (TTM) | 2.48% | ||
| GM | 45.09% |
OM growth 3Y-21.14%
OM growth 5Y-7.77%
PM growth 3Y-35.47%
PM growth 5Y-21.95%
GM growth 3Y-5.43%
GM growth 5Y-2.63%
2. Health
2.1 Basic Checks
SRT3 has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, SRT3 has more shares outstanding
SRT3 has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, SRT3 has an improved debt to assets ratio.
2.2 Solvency
An Altman-Z score of 2.28 indicates that SRT3 is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.28, SRT3 is doing worse than 66.67% of the companies in the same industry.
SRT3 has a debt to FCF ratio of 8.05. This is a slightly negative value and a sign of low solvency as SRT3 would need 8.05 years to pay back of all of its debts.
SRT3 has a worse Debt to FCF ratio (8.05) than 73.33% of its industry peers.
A Debt/Equity ratio of 1.51 is on the high side and indicates that SRT3 has dependencies on debt financing.
SRT3's Debt to Equity ratio of 1.51 is on the low side compared to the rest of the industry. SRT3 is outperformed by 86.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.51 | ||
| Debt/FCF | 8.05 | ||
| Altman-Z | 2.28 |
ROIC/WACC0.48
WACC7.08%
2.3 Liquidity
A Current Ratio of 1.46 indicates that SRT3 should not have too much problems paying its short term obligations.
The Current ratio of SRT3 (1.46) is comparable to the rest of the industry.
SRT3 has a Quick Ratio of 1.46. This is a bad value and indicates that SRT3 is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.92, SRT3 is doing worse than 73.33% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.46 | ||
| Quick Ratio | 0.92 |
3. Growth
3.1 Past
The earnings per share for SRT3 have decreased strongly by -48.38% in the last year.
The Earnings Per Share has been growing by 14.05% on average over the past years. This is quite good.
The Revenue for SRT3 has decreased by -18.66% in the past year. This is quite bad
The Revenue has been growing by 16.74% on average over the past years. This is quite good.
EPS 1Y (TTM)-48.38%
EPS 3Y4.09%
EPS 5Y14.05%
EPS Q2Q%N/A
Revenue 1Y (TTM)-18.66%
Revenue growth 3Y13.29%
Revenue growth 5Y16.74%
Sales Q2Q%7.74%
3.2 Future
SRT3 is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 12.08% yearly.
The Revenue is expected to grow by 6.85% on average over the next years.
EPS Next Y-17.05%
EPS Next 2Y0.97%
EPS Next 3Y8.7%
EPS Next 5Y12.08%
Revenue Next Year-1.28%
Revenue Next 2Y3.1%
Revenue Next 3Y5.47%
Revenue Next 5Y6.85%
3.3 Evolution
The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
SRT3 is valuated quite expensively with a Price/Earnings ratio of 53.49.
80.00% of the companies in the same industry are cheaper than SRT3, based on the Price/Earnings ratio.
SRT3's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 28.79.
Based on the Price/Forward Earnings ratio of 45.35, the valuation of SRT3 can be described as expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of SRT3 indicates a rather expensive valuation: SRT3 more expensive than 80.00% of the companies listed in the same industry.
SRT3's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 21.38.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 53.49 | ||
| Fwd PE | 45.35 |
4.2 Price Multiples
66.67% of the companies in the same industry are cheaper than SRT3, based on the Enterprise Value to EBITDA ratio.
The rest of the industry has a similar Price/Free Cash Flow ratio as SRT3.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 30.2 | ||
| EV/EBITDA | 25.9 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)3.81
EPS Next 2Y0.97%
EPS Next 3Y8.7%
5. Dividend
5.1 Amount
SRT3 has a yearly dividend return of 0.42%, which is pretty low.
SRT3's Dividend Yield is comparable with the industry average which is at 0.92.
With a Dividend Yield of 0.42, SRT3 pays less dividend than the S&P500 average, which is at 2.51.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.42% |
5.2 History
The dividend of SRT3 has a limited annual growth rate of 3.71%.
Dividend Growth(5Y)3.71%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
SRT3 pays out 60.57% of its income as dividend. This is not a sustainable payout ratio.
SRT3's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP60.57%
EPS Next 2Y0.97%
EPS Next 3Y8.7%
FRA:SRT3 (4/25/2025, 5:29:51 PM)
228.4
-1.5 (-0.65%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners2.79%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap17.10B
Analysts77.14
Price Target369.97 (61.98%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.42% |
Yearly Dividend0.74
Dividend Growth(5Y)3.71%
DP60.57%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-13.23%
Min EPS beat(2)-22.4%
Max EPS beat(2)-4.06%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.4%
Min Revenue beat(2)-4.07%
Max Revenue beat(2)4.87%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.7%
PT rev (3m)2.1%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)-1.82%
EPS NY rev (3m)-5.36%
Revenue NQ rev (1m)2.1%
Revenue NQ rev (3m)1.13%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.08%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 53.49 | ||
| Fwd PE | 45.35 | ||
| P/S | 5.06 | ||
| P/FCF | 30.2 | ||
| P/OCF | 17.52 | ||
| P/B | 6.19 | ||
| P/tB | N/A | ||
| EV/EBITDA | 25.9 |
EPS(TTM)4.27
EY1.87%
EPS(NY)5.04
Fwd EY2.2%
FCF(TTM)7.56
FCFY3.31%
OCF(TTM)13.04
OCFY5.71%
SpS45.15
BVpS36.92
TBVpS-36.12
PEG (NY)N/A
PEG (5Y)3.81
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.83% | ||
| ROE | 3.03% | ||
| ROCE | 4.53% | ||
| ROIC | 3.37% | ||
| ROICexc | 3.72% | ||
| ROICexgc | 12.35% | ||
| OM | 11.6% | ||
| PM (TTM) | 2.48% | ||
| GM | 45.09% | ||
| FCFM | 16.75% |
ROA(3y)4.22%
ROA(5y)4.59%
ROE(3y)15.69%
ROE(5y)18.55%
ROIC(3y)8.34%
ROIC(5y)10.45%
ROICexc(3y)8.77%
ROICexc(5y)11.17%
ROICexgc(3y)24.37%
ROICexgc(5y)31.52%
ROCE(3y)11.22%
ROCE(5y)14.06%
ROICexcg growth 3Y-35.26%
ROICexcg growth 5Y-11.95%
ROICexc growth 3Y-38.49%
ROICexc growth 5Y-19.53%
OM growth 3Y-21.14%
OM growth 5Y-7.77%
PM growth 3Y-35.47%
PM growth 5Y-21.95%
GM growth 3Y-5.43%
GM growth 5Y-2.63%
F-Score4
Asset Turnover0.33
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.51 | ||
| Debt/FCF | 8.05 | ||
| Debt/EBITDA | 5.16 | ||
| Cap/Depr | 98.56% | ||
| Cap/Sales | 12.12% | ||
| Interest Coverage | 1.86 | ||
| Cash Conversion | 120.82% | ||
| Profit Quality | 676.58% | ||
| Current Ratio | 1.46 | ||
| Quick Ratio | 0.92 | ||
| Altman-Z | 2.28 |
F-Score4
WACC7.08%
ROIC/WACC0.48
Cap/Depr(3y)148.03%
Cap/Depr(5y)150.65%
Cap/Sales(3y)13.71%
Cap/Sales(5y)12.64%
Profit Quality(3y)282.77%
Profit Quality(5y)224.27%
High Growth Momentum
Growth
EPS 1Y (TTM)-48.38%
EPS 3Y4.09%
EPS 5Y14.05%
EPS Q2Q%N/A
EPS Next Y-17.05%
EPS Next 2Y0.97%
EPS Next 3Y8.7%
EPS Next 5Y12.08%
Revenue 1Y (TTM)-18.66%
Revenue growth 3Y13.29%
Revenue growth 5Y16.74%
Sales Q2Q%7.74%
Revenue Next Year-1.28%
Revenue Next 2Y3.1%
Revenue Next 3Y5.47%
Revenue Next 5Y6.85%
EBIT growth 1Y-22.19%
EBIT growth 3Y-21.66%
EBIT growth 5Y4.31%
EBIT Next Year101.03%
EBIT Next 3Y38.88%
EBIT Next 5Y26.44%
FCF growth 1Y92.68%
FCF growth 3Y7.25%
FCF growth 5Y29.73%
OCF growth 1Y14.36%
OCF growth 3Y4.07%
OCF growth 5Y20.79%